CodeMap®-Quidel Coding Reference

Additional LOINC (Version 2.80) codes for Methotrexate

81627-2-Methotrexate diglutamate [Moles/volume] in Red Blood Cells
81627-2-Methotrexate diglutamate [Moles/volume] in Red Blood Cells
80969-9-Methotrexate free [Mass/volume] in Serum or Plasma
80969-9-Methotrexate free [Mass/volume] in Serum or Plasma
73283-4-Methotrexate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73283-4-Methotrexate induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73282-6-Methotrexate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73282-6-Methotrexate induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
81628-0-Methotrexate monoglutamate [Moles/volume] in Red Blood Cells
81628-0-Methotrexate monoglutamate [Moles/volume] in Red Blood Cells
81624-9-Methotrexate pentaglutamate [Moles/volume] in Red Blood Cells
81624-9-Methotrexate pentaglutamate [Moles/volume] in Red Blood Cells
81630-6-Methotrexate polyglutamates 1-5 and total panel - Red Blood Cells
81630-6-Methotrexate polyglutamates 1-5 and total panel - Red Blood Cells
81631-4-Methotrexate polyglutamates [Interpretation] in Red Blood Cells Narrative
81631-4-Methotrexate polyglutamates [Interpretation] in Red Blood Cells Narrative
76351-6-Methotrexate polyglutamates [Moles/volume] in Red Blood Cells
76351-6-Methotrexate polyglutamates [Moles/volume] in Red Blood Cells
81625-6-Methotrexate tetraglutamate [Moles/volume] in Red Blood Cells
81625-6-Methotrexate tetraglutamate [Moles/volume] in Red Blood Cells
81626-4-Methotrexate triglutamate [Moles/volume] in Red Blood Cells
81626-4-Methotrexate triglutamate [Moles/volume] in Red Blood Cells
34599-1-Methotrexate [Mass/volume] in Body fluid
34599-1-Methotrexate [Mass/volume] in Body fluid
3792-9-Methotrexate [Mass/volume] in Cerebral spinal fluid
3792-9-Methotrexate [Mass/volume] in Cerebral spinal fluid
3793-7-Methotrexate [Mass/volume] in Serum or Plasma
3793-7-Methotrexate [Mass/volume] in Serum or Plasma
3794-5-Methotrexate [Mass/volume] in Serum or Plasma --1-2 weeks post dose
3794-5-Methotrexate [Mass/volume] in Serum or Plasma --1-2 weeks post dose
3795-2-Methotrexate [Mass/volume] in Serum or Plasma --24 hours post dose
3795-2-Methotrexate [Mass/volume] in Serum or Plasma --24 hours post dose
3796-0-Methotrexate [Mass/volume] in Serum or Plasma --48 hours post dose
3796-0-Methotrexate [Mass/volume] in Serum or Plasma --48 hours post dose
3797-8-Methotrexate [Mass/volume] in Serum or Plasma --72 hours post dose
3797-8-Methotrexate [Mass/volume] in Serum or Plasma --72 hours post dose
17266-8-Methotrexate [Mass/volume] in Urine
17266-8-Methotrexate [Mass/volume] in Urine
4324-0-Methotrexate [Mass] of Dose
4324-0-Methotrexate [Mass] of Dose
34628-8-Methotrexate [Moles/volume] in Cerebral spinal fluid
34628-8-Methotrexate [Moles/volume] in Cerebral spinal fluid
14836-1-Methotrexate [Moles/volume] in Serum or Plasma
14836-1-Methotrexate [Moles/volume] in Serum or Plasma
70098-9-Methotrexate [Moles/volume] in Serum or Plasma --10th specimen
70098-9-Methotrexate [Moles/volume] in Serum or Plasma --10th specimen
51599-9-Methotrexate [Moles/volume] in Serum or Plasma --12 hours post dose
51599-9-Methotrexate [Moles/volume] in Serum or Plasma --12 hours post dose
98990-5-Methotrexate [Moles/volume] in Serum or Plasma --18 hour post dose
98990-5-Methotrexate [Moles/volume] in Serum or Plasma --18 hour post dose
51600-5-Methotrexate [Moles/volume] in Serum or Plasma --24 hours post dose
51600-5-Methotrexate [Moles/volume] in Serum or Plasma --24 hours post dose
70099-7-Methotrexate [Moles/volume] in Serum or Plasma --2nd specimen
70099-7-Methotrexate [Moles/volume] in Serum or Plasma --2nd specimen
70100-3-Methotrexate [Moles/volume] in Serum or Plasma --3rd specimen
70100-3-Methotrexate [Moles/volume] in Serum or Plasma --3rd specimen
51601-3-Methotrexate [Moles/volume] in Serum or Plasma --4 hours post dose
51601-3-Methotrexate [Moles/volume] in Serum or Plasma --4 hours post dose
51611-2-Methotrexate [Moles/volume] in Serum or Plasma --48 hours post dose
51611-2-Methotrexate [Moles/volume] in Serum or Plasma --48 hours post dose
70101-1-Methotrexate [Moles/volume] in Serum or Plasma --4th specimen
70101-1-Methotrexate [Moles/volume] in Serum or Plasma --4th specimen
98991-3-Methotrexate [Moles/volume] in Serum or Plasma --5 minutes post dose
98991-3-Methotrexate [Moles/volume] in Serum or Plasma --5 minutes post dose
70102-9-Methotrexate [Moles/volume] in Serum or Plasma --5th specimen
70102-9-Methotrexate [Moles/volume] in Serum or Plasma --5th specimen
70103-7-Methotrexate [Moles/volume] in Serum or Plasma --6th specimen
70103-7-Methotrexate [Moles/volume] in Serum or Plasma --6th specimen
51602-1-Methotrexate [Moles/volume] in Serum or Plasma --72 hours post dose
51602-1-Methotrexate [Moles/volume] in Serum or Plasma --72 hours post dose
70104-5-Methotrexate [Moles/volume] in Serum or Plasma --7th specimen
70104-5-Methotrexate [Moles/volume] in Serum or Plasma --7th specimen
70105-2-Methotrexate [Moles/volume] in Serum or Plasma --8th specimen
70105-2-Methotrexate [Moles/volume] in Serum or Plasma --8th specimen
70106-0-Methotrexate [Moles/volume] in Serum or Plasma --9th specimen
70106-0-Methotrexate [Moles/volume] in Serum or Plasma --9th specimen

LOINC Copyright Copyright © 2023 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2023, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.

04/25/2025 12:44:12 3.141.167.59